中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
11期
1639-1641
,共3页
痴呆,血管性%参乌益智胶囊
癡呆,血管性%參烏益智膠囊
치태,혈관성%삼오익지효낭
Dementia,vascular%Shenwuyizhi capsule
目的 观察参乌益智胶囊治疗血管性痴呆的临床疗效.方法 将80例血管性痴呆患者数字表法随机分为对照组和治疗组,每组40例.在常规治疗基础上,对照组予吡拉西坦片口服,治疗组予以参乌益智胶囊口服.60d为1个疗程.比较治疗前后简单智力状况检查(MMSE)量表积分、Blessed行为量表积分变化.结果 两组治疗前后MMSE积分、Bcessed行为量表积分均明显改善(均P＜0.05)；治疗后治疗组MMSE积分、Bcessed行为量表积分分别为(19.83±5.24)分、(7.18±4.21)分,均优于对照组的(20.01±4.89)分、(7.23±3.99)分(t=4.148,2.141,均P＜0.05).结论 参乌益智胶囊能改善轻、中度血管性痴呆患者认知功能,提高患者记忆力、计算力、定向力,增强患者行为能力,减轻痴呆症状,取得较好近期疗效.
目的 觀察參烏益智膠囊治療血管性癡呆的臨床療效.方法 將80例血管性癡呆患者數字錶法隨機分為對照組和治療組,每組40例.在常規治療基礎上,對照組予吡拉西坦片口服,治療組予以參烏益智膠囊口服.60d為1箇療程.比較治療前後簡單智力狀況檢查(MMSE)量錶積分、Blessed行為量錶積分變化.結果 兩組治療前後MMSE積分、Bcessed行為量錶積分均明顯改善(均P＜0.05)；治療後治療組MMSE積分、Bcessed行為量錶積分分彆為(19.83±5.24)分、(7.18±4.21)分,均優于對照組的(20.01±4.89)分、(7.23±3.99)分(t=4.148,2.141,均P＜0.05).結論 參烏益智膠囊能改善輕、中度血管性癡呆患者認知功能,提高患者記憶力、計算力、定嚮力,增彊患者行為能力,減輕癡呆癥狀,取得較好近期療效.
목적 관찰삼오익지효낭치료혈관성치태적림상료효.방법 장80례혈관성치태환자수자표법수궤분위대조조화치료조,매조40례.재상규치료기출상,대조조여필랍서탄편구복,치료조여이삼오익지효낭구복.60d위1개료정.비교치료전후간단지력상황검사(MMSE)량표적분、Blessed행위량표적분변화.결과 량조치료전후MMSE적분、Bcessed행위량표적분균명현개선(균P＜0.05)；치료후치료조MMSE적분、Bcessed행위량표적분분별위(19.83±5.24)분、(7.18±4.21)분,균우우대조조적(20.01±4.89)분、(7.23±3.99)분(t=4.148,2.141,균P＜0.05).결론 삼오익지효낭능개선경、중도혈관성치태환자인지공능,제고환자기억력、계산력、정향력,증강환자행위능력,감경치태증상,취득교호근기료효.
Objective To observe the clinical effect of Shenwuyizhi capsule in the treatment of vascular dementia.Methods According to the digital table method,80 patients with vascular dementia were divided into the treatment group and control group,each group with 40 cases.On the basis of routine treatment,the control group was treated with piracetam tablets,and the treatment group was treated by the Shenwuyizhi capsule.60 d for 1 course.Before and after treatment,the simple mental state examination(MMSE) scale scores,Blessed behavior scale scores were compared between the two groups.Results Before and after treatment,the MMSE score,Bcessed behavior scale scores of the two groups were significantly improved (all P ＜ 0.05).After treatment,the MMSE score,Bcessed behavior scale scores of the treatment group were (19.83 ± 5.24) points,(7.18 ± 4.21) points,respectively,which were better than those of the control group [(20.01 ± 4.89) points,(7.23 ± 3.99) points] (t =4.148,2.141,all P ＜0.05).Conclusion Shenwuyizhi capsule can improve the light,moderate cognitive function in patients with vascular dementia,and improve memory and computing power,directional force,and enhance patient behavior ability,and reduce dementia symptoms,with good curative effect in the near future.
